Search hospitals > Missouri > Springfield

Mercy Hospital Springfield

Claim this profile
Springfield, Missouri 65804
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Ovarian Cancer
Conducts research for Breast cancer
Conducts research for Cancer
397 reported clinical trials
3 medical researchers
Photo of Mercy Hospital Springfield in SpringfieldPhoto of Mercy Hospital Springfield in SpringfieldPhoto of Mercy Hospital Springfield in Springfield

Summary

Mercy Hospital Springfield is a medical facility located in Springfield, Missouri. This center is recognized for care of Breast Cancer, Lung Cancer, Ovarian Cancer, Breast cancer, Cancer and other specialties. Mercy Hospital Springfield is involved with conducting 397 clinical trials across 514 conditions. There are 3 research doctors associated with this hospital, such as Jay W Carlson, Madhu Kalyan Pendurthi, MD, and Sunthosh V. Parvathaneni, MD FHRS FACC.

Area of expertise

1Breast Cancer
Global Leader
Mercy Hospital Springfield has run 65 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 negative
ER positive
2Lung Cancer
Global Leader
Mercy Hospital Springfield has run 56 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage II
Stage I

Top PIs

Clinical Trials running at Mercy Hospital Springfield

Lung Cancer
Breast Cancer
Breast cancer
Prostate Cancer
Ovarian Cancer
Esophageal cancer
Cancer
Colorectal Cancer
Multiple Myeloma
Melanoma
Image of trial facility.

Radiation Therapy

for Brain Metastasis

This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Image of trial facility.

Proton Craniospinal Radiation

for Cancer in the Brain and Spinal Cord

This phase III trial compares proton craniospinal irradiation (pCSI) to involved-field radiation therapy (IFRT) for the treatment of breast or non-small cell lung cancer that has spread from where it first started to the cerebrospinal fluid filled space that surrounds the brain and spinal cord (leptomeningeal metastasis). Patients with leptomeningeal metastasis (LM) may develop multiple areas of nervous system (neurologic) impairment that can be life-threatening. Radiation therapy (RT) effectively relieves local symptoms due to LM. RT uses high energy radiography (x-rays), particles, or radioactive seeds to kill cancer cells and shrink tumors. IFRT is commonly used to treat symptoms of LM. IFRT is radiation treatment that uses x-rays to treat specific areas of LM and to relieve and/or prevent symptoms. pCSI uses protons that can be directed with more accuracy than x-rays which allows treatment of the entire central nervous system space containing the cerebrospinal fluid (CSF), brain, and spinal cord. The pCSI treatment could delay the worsening of LM. Giving pCSI may be better than IFRT in treating LM in patients with breast or non-small cell lung cancer.
Recruiting2 awards Phase 33 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Mercy Hospital Springfield?
Where is Mercy Hospital Springfield located?
Who should I call to ask about financial aid or insurance network?
What insurance does Mercy Hospital Springfield accept?
What awards or recognition has Mercy Hospital Springfield received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security